Tumor-treating fields therapy uses alternating electric fields of intermediate frequency and low intensity to disrupt processes critical in the survival of cancer cells.
Representatives from regulatory authorities of the countries of Malaysia, Australia and South Korea discussed their respective challenges in the “International Drug-Device Combinations Session” at DIA Europe 2023.